Bristol Myers Squibb Devens facility joins WEF Global Lighthouse list
Updated
Updated · The New York Times · May 6
Bristol Myers Squibb Devens facility joins WEF Global Lighthouse list
12 articles · Updated · The New York Times · May 6
The Massachusetts plant was one of 23 sites recognised this year and the only US manufacturer selected.
It uses AI to track temperature, oxygen, pH and other variables in bioreactors making cancer-drug proteins, helping technicians intervene early and reduce production failures that can cause shortages.
Since 2018, 14 US factories have made the network versus 99 in China, underscoring broader US difficulties turning AI leadership into factory-floor gains.
Can the U.S. overcome its talent and infrastructure gaps to match China's rapid AI-driven manufacturing growth in the next decade?
How might AI integration in drug manufacturing reshape patient safety, drug availability, and regulatory oversight in the coming years?